These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5869772)

  • 21. [Labor Safety Board has different viewpoint: working with cytostatics not hazardous for pregnant women].
    Lernevall I
    Vardfacket; 1984 Oct; 8(18):31. PubMed ID: 6570915
    [No Abstract]   [Full Text] [Related]  

  • 22. [Reversed isolation for patients undergoing cytostatics therapy. Patients with lowered resistance need to be protected from germs].
    Vormann A
    Pflege Z; 1997 Oct; 50(10):585-9. PubMed ID: 9456803
    [No Abstract]   [Full Text] [Related]  

  • 23. [Heart damage after treatment of neoplasms with cytostatics].
    Wilk J
    Pol Tyg Lek; 1983 Jul; 38(27):853-5. PubMed ID: 6361712
    [No Abstract]   [Full Text] [Related]  

  • 24. [Damage to the oral mucosa after treatment with cytostatics].
    Bartáková V; Drízhal I
    Cesk Stomatol; 1982 Dec; 82(6):412-7. PubMed ID: 6961959
    [No Abstract]   [Full Text] [Related]  

  • 25. [Severe fatigue in cancer. Causes from A as anemia to Z as cytostatics].
    MMW Fortschr Med; 2004 Mar; 146(11):57. PubMed ID: 15152776
    [No Abstract]   [Full Text] [Related]  

  • 26. ['It is especially a question of attentive and systematic working'--new manual cytostatics].
    van de Pasch T
    TVZ; 1998 Jan; 108(1):9-11. PubMed ID: 9526433
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pulmonary damage caused by cytostatics and paraquat (author's transl)].
    Fischer G; Wöltjen HH; Schauer A
    Rontgenblatter; 1981 Sep; 34(9):331-7. PubMed ID: 6169136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Workmen's Protection Committee's proposal: pregnant women should not get jobs with cytostatics. Interview by Inger Lernevall].
    Lundberg S
    Vardfacket; 1983 Sep; 7(16):30-1. PubMed ID: 6557730
    [No Abstract]   [Full Text] [Related]  

  • 29. [Problem of tolerance and biological availability in the treatment with cytostatics].
    Czownicki Z
    Pol Tyg Lek; 1980 Dec; 35(51):2015-8. PubMed ID: 7017633
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluating the potential hazard of handling antineoplastic drugs.
    Gallelli JF
    Am J Hosp Pharm; 1982 Nov; 39(11):1877. PubMed ID: 7148851
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cardiotoxicity of antineoplastic therapy].
    Elbl L; Vásová I; Kiss I; Chaloupka V; Kubesová H; Vorlícek J
    Vnitr Lek; 2000 Mar; 46(3):178-83. PubMed ID: 11048523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Incidence and degree of intolerance and toxic effect of cytostatics in the treatment of lung cancer].
    Traczyk K; Zych D; Decker E; Radziukiewicz-Byszewska D; Krychniak W; Marzinek M; Pecyna-Sielewicz J; Ponahajba A; Siekierzyńska A; Słupek A
    Pneumonol Pol; 1980; 48(12):831-40. PubMed ID: 7220354
    [No Abstract]   [Full Text] [Related]  

  • 33. Antineoplastics: a safety hazard?
    Wilson JP; Solimando DA
    Am J Hosp Pharm; 1981 May; 38(5):624. PubMed ID: 7282687
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of the indication of carcinostatic agents and prediction of their adverse effects].
    Kondo T; Okubo K; Imamura T; Iwatsuki Y
    Gan No Rinsho; 1966 Mar; 12(3):149-53. PubMed ID: 6010935
    [No Abstract]   [Full Text] [Related]  

  • 35. [Disorders of the cardiovascular system during treatment of oncologic diseases].
    Elbl L
    Vnitr Lek; 2002 Jul; 48(7):619-25. PubMed ID: 12197403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health and safety in the workplace--part 6. Chemotherapy hazard.
    Bartkowski-Dodds L
    Calif Nurse; 1983 May; 78(10):5. PubMed ID: 6552922
    [No Abstract]   [Full Text] [Related]  

  • 37. [New trends in antineoplastic chemotherapy].
    Klener P
    Vnitr Lek; 1994 Jun; 40(6):386-90. PubMed ID: 8073651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Health effects of occupational exposure to cytostatics in medicinal personnel in the light of compulsory prophylactics: a cross-sectional study].
    Walusiak J; Wagrowska-Koski E; Pałczyński C
    Med Pr; 2003; 54(3):229-36. PubMed ID: 14669575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Present status in the development of new antineoplastic agents].
    Klener P
    Cas Lek Cesk; 1994 Jan; 133(1):6-9. PubMed ID: 8111834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The problem of accidental paravenous application of cytostatics--case history (author's transl)].
    Sommer H; Meinhold P
    Zentralbl Gynakol; 1981; 103(21):1324-8. PubMed ID: 6798785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.